ACKR2 in Hematopoietic Precursors as a Checkpoint of Neutrophil Release and Anti-Metastatic Activity

Nature Communications - United Kingdom
doi 10.1038/s41467-018-03080-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neutrophil Lymphocyte Ratio and Duration of Prior Anti-Angiogenic Therapy as Biomarkers in Metastatic RCC Receiving Immune Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Molecular Mechanisms of Anti-Metastatic Activity of Curcumin

Anticancer Research
MedicineCancer ResearchOncology
2016English

Peroxynitrite Enhances Interleukin-10 Reduction in the Release of Neutrophil Chemotactic Activity

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2003English

Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Correction: Mesenchymal Stem Cells Augment the Anti-Bacterial Activity of Neutrophil Granulocytes

PLoS ONE
Multidisciplinary
2014English

The Mitochondrial Metabolic Checkpoint and Aging of Hematopoietic Stem Cells

Current Opinion in Hematology
Hematology
2016English

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

Frontiers in Immunology
AllergyImmunology
2018English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy